Guest Editorial: Biomarkers of Perfluorinated Chemicals and Birth Weight by Savitz, David A.
Two articles (Apelberg 2007; Fei 2007) appearing in this issue of
Environmental Health Perspectives evaluate the relationship of perfluo-
rooctanoate (PFOA) and perfluororooctane sulfonate (PFOS) with
birth weight; they constitute the first rigorous epidemiologic studies
to address this topic. The ubiquity of these chemicals in the environ-
ment and in humans and the growing concerns about potential
health effects from such toxicants make these studies a valuable addi-
tion to the health effects literature. The ultimate implications of these
studies concerning etiologic relationships with human health remain
to be elucidated, but they raise two important issues: the interpreta-
tion of small shifts in birth weight, and the potential for shared deter-
minants of exposure biomarkers and biological indicators of health
outcome. 
Birth weight offers many advantages as an end point for studies
of environmental agents. It is measured easily and accurately, shows
substantial variability, and has been proven to be sensitive to envi-
ronmental insults, most notably tobacco smoke (Wilcox and Russell
1983; Windham et al. 2000). Because birth weight is measured on a
continuous scale, even moderate-size studies often have excellent
statistical power to detect small decrements. On the other hand,
such shifts in birth weight, even if ultimately proven to be causal,
reflect variation within the normal range of the distribution, in
which there appears to be few or no direct consequences for infant
mortality or morbidity (Wilcox 2001). Even when there are rela-
tively large shifts in birth weight, as associated with altitude or ciga-
rette smoking, there do not appear to be adverse effects mediated by
the shift in mean birth weight per se. Although shifts in the entire
distribution would be expected to increase the number of births at
the extreme low end, in fact it seems that influences on the domi-
nant part of the birth weight distribution operate separately from
determinants of the extreme residual end of the scale (Wilcox 2001;
Wilcox and Russell 1983). When studies measure changes in mean
birth weight, the results reflect only the dominant distribution—the
normal ranges. The same is true for gestational age: Changes in
mean gestational age at birth tell us little about changes in the risk
of preterm birth, and instead reflect changes in the normal 38- to
40-week range where most births occur. The number of births
falling into the residual tail of the distribution determines the clini-
cal and public health outcomes of importance. In contrast, blood
pressure, body mass index (BMI), and blood glucose levels appear
to affect risk of cardiovascular disease on a continuous scale across
the full range, so that shifts in the entire distribution are highly
influential (Rose 1985).
In the study by Apelberg et al. (2007), the strongest association
was found between PFOA and birth weight, with a log unit change
(2.7-fold increase) in exposure associated with a 104-g [95% confi-
dence interval (CI), –5 to 213 g] reduction in weight. A log unit
change in PFOS predicted a 69-g (95% CI, –10 to 149 g) reduc-
tion. In the study by Fei et al. (2007), PFOA was associated with
birth weight, with a decrement of 10.6 g (95% CI, 0.5 to 20.8) per
nanogram per milliliter change in exposure, and essentially no asso-
ciation was found for PFOS. Neither study provided support for a
change in risk of low birth weight as con-
ventionally defined (< 2,500 g), presum-
ably reflecting modest shifts in the overall
distribution without any enhanced effect
on the tail. Given the differences in which
agent was implicated, variation in ranges
of exposure studied, and modest effect
sizes, the evidence linking PFOA or PFOS and birth weight remains
ambiguous. But if the link is confirmed, it would suggest biological
(not necessarily pathological) effects of exposure in humans. The
reported variations in head circumference and ponderal index share
the same concerns—uncertain implications of small variation in the
normal range (Apelberg et al. 2007). 
A second concern when relating a biomarker of exposure to a
measure of normal biological variation is the possibility that both
reflect shared maternal physiology. In the case of exposure to PFOA
and PFOS in communities lacking distinctive environmental
sources, as in these two studies, interindividual variation can result
from specific sources of external exposure associated with residence,
occupation, or lifestyle, or from all persons having similar, more or
less random environmental exposures, but differing in uptake and
excretion. Fei et al. (2007) report that higher exposure was associ-
ated with young maternal age, low parity, elevated BMI, and being
a nonsmoker. Age, parity, and BMI may well reflect interindividual
differences in uptake and excretion rather than differences in exoge-
nous environmental exposure. We have much to learn about the
pathways leading to elevated blood levels of PFOA and PFOS, but
to the extent that metabolic differences among individuals deter-
mine their blood levels, such differences could also produce con-
comitant variation in birth weight and infant adiposity.
Hypothetically, if maternal physiology influenced both exposure
biomarkers and blood glucose levels, for example, biomarkers in
exposure and outcome would be associated due to a common
influence, rather than exposure affecting outcome. Although this is
highly speculative, tendencies in this direction could well account
for the modest associations between exposure biomarkers and
biological variability in infant size.
The challenge faced by these and future investigators is to isolate
causal effects of the exposure on the outcome from shared intrinsic
determinants producing noncausal associations, that is, confounders.
To the degree that these shared influences can be measured, they can
be controlled statistically. The magnitude of change from simply
controlling for the few markers of exposure that are independently
related to health outcomes markedly attenuated the risk estimates in
both of the studies, nonetheless leaving discernible indications of a
weaker association. Several strategies could help future studies to dis-
tinguish shared biological determinants of measured exposure and
outcome from a causal effect: First, examine an exposure distribution
that extends above the range of normal variation so that blood levels
reflect interindividual differences in exogenous exposure and not just
individual differences in uptake and excretion. Second, conduct
studies that are large enough to address clinically significant out-
A 528 VOLUME 115 | NUMBER 11 | November 2007 • Environmental Health Perspectives
Guest Editorial
Biomarkers of Perfluorinated Chemicals
and Birth Weight
doi:10.1289/ehp.10923
David A. Savitz
Perspectives EditorialEnvironmental Health Perspectives • VOLUME 115 | NUMBER 11 | November 2007 A 529
Editorial
comes, including those that fall outside the range of normal biologi-
cal variability. Finally, identify and adjust for improved markers of
maternal and fetal physiology that may influence measured blood
levels of the exposure and independently affect the health outcomes
of interest. 
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